Pfizer Ltd India (PFIZER):企業の財務・戦略的SWOT分析

◆英語タイトル:Pfizer Ltd India (PFIZER) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14827
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pfizer Ltd India (Pfizer India), a subsidiary of Pfizer Inc, is a pharmaceutical company that develops medicines for brain disorders. The company’s products portfolio comprises of anti-allergics, anti-diabetics, anti-histamines, anti-infectives, anti-parasitics, drugs for cardiovascular and dermatological conditions, erectile dysfunction, GI infections, multivitamins, medicines for neurological conditions, pain, fever, inflammation and autoimmune disorders, besides vitamins and minerals among others. Pfizer India offers medicines to treat Alzheimer’s disease, autism, bipolar disorder, depression, Parkinson’s disease, schizophrenia and others. It also provides patient assistance programs for glaucoma, breast cancer and neuropathic pain. The company conducts research to develop drugs for cancer, arthritis and osteoporosis. Pfizer India is headquartered in Mumbai, Maharashtra, India.

Pfizer Ltd India Key Recent Developments

Jan 15,2019: Pfizer offers severance package to employees of Chennai, Aurangabad units
Jan 09,2019: Pfizer to stop manufacturing operations in Chennai, Aurangabad units
Jan 08,2019: Pfizer to exit two more plants in India
Nov 14,2018: Pfizer announces appointment of Mr. Milind Patil as Executive Director
Aug 16,2018: Pfizer names Mr. Milind Patil as Chief Financial Officer

This comprehensive SWOT profile of Pfizer Ltd India provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pfizer Ltd India including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Pfizer Ltd India – Key Information
Pfizer Ltd India – Overview
Pfizer Ltd India – Key Employees
Pfizer Ltd India – Key Employee Biographies
Pfizer Ltd India – Key Operational Heads
Pfizer Ltd India – Major Products and Services
Pfizer Ltd India – History
Pfizer Ltd India – Company Statement
Pfizer Ltd India – Locations And Subsidiaries
Pfizer Ltd India – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Pfizer Ltd India – Business Description
Pfizer Ltd India – Corporate Strategy
Pfizer Ltd India – SWOT Analysis
SWOT Analysis – Overview
Pfizer Ltd India – Strengths
Pfizer Ltd India – Weaknesses
Pfizer Ltd India – Opportunities
Pfizer Ltd India – Threats
Pfizer Ltd India – Key Competitors

Section 3 – Company Financial Performance Charts

Pfizer Ltd India – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Pfizer Ltd India, Key Information
Pfizer Ltd India, Key Ratios
Pfizer Ltd India, Share Data
Pfizer Ltd India, Major Products and Services
Pfizer Ltd India, History
Pfizer Ltd India, Key Employees
Pfizer Ltd India, Key Employee Biographies
Pfizer Ltd India, Key Operational Heads
Pfizer Ltd India, Other Locations
Pfizer Ltd India, Subsidiaries
Pfizer Ltd India, Key Manufacturing facilities
Pfizer Ltd India, Key Competitors
Pfizer Ltd India, SWOT Analysis
Pfizer Ltd India, Ratios based on current share price
Pfizer Ltd India, Annual Ratios
Pfizer Ltd India, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Pfizer Ltd India, Performance Chart
Pfizer Ltd India, Ratio Charts

★海外企業調査レポート[Pfizer Ltd India (PFIZER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Glencore Plc:企業のM&A・事業提携・投資動向
    Glencore Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glencore Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • GGP Inc:企業の戦略・SWOT・財務情報
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • AVEO Pharmaceuticals Inc (AVEO):製薬・医療:M&Aディール及び事業提携情報
    Summary AVEO Pharmaceuticals Inc (AVEO) is a biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of various types of cancers. Its proprietary platform delivers insights into cancer and related diseases. AVEO develops its lead candida …
  • Greenphire Inc:医療機器:M&Aディール及び事業提携情報
    Summary Greenphire Inc (Greenphire) is a provider of clinical trial payment solutions that offers patients reimbursement and site payments. The company’s products portfolio includes ClinCard, ConneXTS and eClinicalGPS. Its eClinicalGPS is a global site that facilitates accurate payment calculation, …
  • Sojitz Corp (2768):企業の財務・戦略的SWOT分析
    Sojitz Corp (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AIA Group Limited:戦略・SWOT・企業財務分析
    AIA Group Limited - Strategy, SWOT and Corporate Finance Report Summary AIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Therapeutic Solutions International Inc (TSOI):製薬・医療:M&Aディール及び事業提携情報
    Summary Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that offers supplements. The company offers products such as DermalStilbene, NanoStilbene and ProJuvenol. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for …
  • The Wistar Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training. The institute performs research in the areas of cancer, infectious diseases, immunology and vaccine development. It also conducts research on genes, gene expression, and DNA biolo …
  • NCI Building Systems, Inc. (NCS):企業の財務・戦略的SWOT分析
    NCI Building Systems, Inc. (NCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SPH REIT Management Pte Ltd:企業の戦略・SWOT・財務情報
    SPH REIT Management Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary SPH REIT Management Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • HollyFrontier Corp (HFC):石油・ガス:M&Aディール及び事業提携情報
    Summary HollyFrontier Corp (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, heavy pro …
  • Murmanskoye Morskoye Parokhodstvo:企業の戦略・SWOT・財務分析
    Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report Summary Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Hochschild Mining plc:企業の戦略・SWOT・財務情報
    Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report Summary Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mannai Corporation QSC:企業のM&A・事業提携・投資動向
    Mannai Corporation QSC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mannai Corporation QSC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Color Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Color Genomics, Inc. (Color) provides physician ordered genetic testing service that helps to identify hereditary cancer risk. The company’s clinical grade test provides actionable results that enable consumers and their doctors to create personalized screening and healthcare plan. Color ana …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • JSHP Transformer Co Ltd:企業の戦略的SWOT分析
    JSHP Transformer Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • iVascular SLU:製品パイプライン分析
    Summary iVascular SLU (iVascular) designs, develops and manufactures advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. It offers portfolio of products in the fields of interventional cardiology, endovascular intervention and interventional neuroradio …
  • Apollo Education Group Inc:企業の戦略的SWOT分析
    Apollo Education Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Jadason Enterprises Limited (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Limited (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆